Margo Heath-Chiozzi - 08 Dec 2021 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
SVP of Regulatory Affairs
Signature
/s/ Sam Martin, attorney-in-fact for Margo Heath-Chiozzi
Issuer symbol
CLDX
Transactions as of
08 Dec 2021
Transactions value $
-$22,332
Form type
4
Filing time
10 Dec 2021, 15:02:38 UTC
Previous filing
03 Nov 2021
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLDX Common Stock Options Exercise $1,668 +600 +5.3% $2.78* 11,847 08 Dec 2021 Direct
transaction CLDX Common Stock Sale -$24,000 -600 -5.1% $40 11,247 08 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (Right to Buy) Options Exercise $0 -600 -1.4% $0 41,800 08 Dec 2021 Common Stock 600 $2.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on August 13, 2021.
F2 25 % vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.